1. Home
  2. NPKI vs VIR Comparison

NPKI vs VIR Comparison

Compare NPKI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$14.39

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.03

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
VIR
Founded
1932
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NPKI
VIR
Price
$14.39
$9.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$14.17
$29.30
AVG Volume (30 Days)
619.9K
2.9M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$26.96
N/A
Revenue Next Year
$13.16
$131.58
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.76
$4.16
52 Week High
$15.85
$10.91

Technical Indicators

Market Signals
Indicator
NPKI
VIR
Relative Strength Index (RSI) 54.04 62.52
Support Level $13.53 $4.88
Resistance Level $14.58 N/A
Average True Range (ATR) 0.70 0.58
MACD -0.03 0.16
Stochastic Oscillator 40.23 51.86

Price Performance

Historical Comparison
NPKI
VIR

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: